Fdcsp is an immune-associated prognostic biomarker in hpv-positive head and neck squamous carcinoma

HIGHLIGHTS

• who: Qingqing Wu and colleagues from the Department of Oral and Maxillofacial Surgery, NanFang Hospital, Southern Medical University, Guangzhou, China have published the Article: FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma, in the Journal: Biomolecules 2022, 12, x FOR PEER REVIEW of /2022/
• what: Based on the better prognosis of HPV+ HNSC, the authors intended to focus on which genes or proteins inhibited tumor progression, so the authors focused on genes that were highly expressed in HPV+ HNSC. Based on gene function and viral infection, the authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.